Overview

Dexmedetomidine Versus Propofol in Vitreoretinal Surgery

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The investigators would like to determine if using Dexmedetomidine alone or in a reduced dose can prevent or reduce the incidence of adverse effects, while providing adequate sedation, and respiratory stability as compared to propofol.
Phase:
Phase 4
Details
Lead Sponsor:
Rutgers, The State University of New Jersey
Treatments:
Dexmedetomidine
Propofol